Back to search
Endocarditis, Bacterial
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Endocarditis, Bacterial trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Endocarditis, Bacterial trials you may qualify forProspective observational study designed to describe the clinical, laboratory, imaging, microbiological characteristics and treatment of specific infectious dis…
How does health develop after Infective endocarditis (IE)? Can the health of patients with IE be improved by participation in the physical exercise training wit…
1\. Infective Endocarditis (IE) is a rare and serious disease with high morbidity and mortality; 2. Streptoccoci of oral origin are the second more frequent mic…
Infective endocarditis (IE) is an endocardial lesion caused by bacterial and/or fungal infection that most commonly affects the heart valves and/or the endocard…
Non-inferiority trial to determine whether partial oral treatment is non-inferior to OPAT(Outpatient parenteral therapy) in patients diagnosed with infective en…
There is a variety of in vitro, in vivo (animal model), and human case series data which suggests that the addition of ertapenem to cefazolin could improve outc…
Cardiac infections, including infective endocarditis and cardiovascular implantable electronic device infections, are associated with substantial morbidity and…
This study will assess the efficacy of an integrated outpatient treatment model for persons with opioid use disorder and injection related infections. The inves…